Evidence map›Paper›PMID 35629126›Full record

ArticleJournal of personalized medicine2022

Classification of Huntington's Disease Stage with Features Derived from Structural and Diffusion-Weighted Imaging.

Rui Lavrador, Filipa Júlio, Cristina Januário, Miguel Castelo-Branco, Gina Caetano

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Rui LavradorCNC.IBILI-Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
Filipa JúlioCIBIT-Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, 3000-548 Coimbra, Portugal.ORCID 0000-0001-6075-6887
Cristina JanuárioCIBIT-Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, 3000-548 Coimbra, Portugal.ORCID 0000-0001-5402-3978
Miguel Castelo-BrancoCNC.IBILI-Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
Gina CaetanoCNC.IBILI-Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.ORCID 0000-0001-6878-6079
University of Coimbra · PTHospitais da Universidade de Coimbra · PTUniversity of Lisbon · PT

Funding

Fundação para a Ciência e Tecnologia Programa Ciência 2008Fundação para a Ciência e Tecnologia PTDC/SAU-ENB/112306/2009Fundação para a Ciência e Tecnologia strategic project/structural funds COMPETE, POCI-01-0145-FEDER-007440, and UID/NEU/04539/2013-2020
6 · The paper itself

Abstract

The purpose of this study was to classify Huntington’s disease (HD) stage using support vector machines and measures derived from T1- and diffusion-weighted imaging. The effects of feature selection approach and combination of imaging modalities are assessed. Fourteen premanifest-HD individuals (Pre-HD; on average > 20 years from estimated disease onset), eleven early-manifest HD (Early-HD) patients, and eighteen healthy controls (HC) participated in the study. We compared three feature selection approaches: (i) whole-brain segmented grey matter (GM; voxel-based measure) or fractional anisotropy (FA) values; (ii) GM or FA values from subcortical regions-of-interest (caudate, putamen, pallidum); and (iii) automated selection of GM or FA values with the algorithm Relief-F. We assessed single- and multi-kernel approaches to classify combined GM and FA measures. Significant classifications were achieved between Early-HD and Pre-HD or HC individuals (accuracy: generally, 85% to 95%), and between Pre-HD and controls for the feature FA of the caudate ROI (74% accuracy). The combination of GM and FA measures did not result in higher performances. We demonstrate evidence on the high sensitivity of FA for the classification of the earliest Pre-HD stages, and successful distinction between HD stages.

Indexed as

basal gangliaclassificationfractional anisotropygrey matter densityHuntington’s diseasesupport vector machine

Identifiers

PMID35629126
PMCPMC9143912
OpenAlexW4225140891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.